The Company
Aviex is a leading-edge biotechnology company that is developing potent vaccines that are administered orally and/or by multi-modality utilizing a novel patented vaccine platform delivery technology.
The Aviex Platform is designed to deliver preventative and therapeutic vaccines for a wide range of human and animal infectious diseases caused by bacterial and parasitic pathogens. The company mission is to develop an ongoing pipeline of vaccine products utilizing the YS1646-based Aviex patented platform delivery technology.